Filed: 5/14/2026ACC: 0001193125-26-223563
📋 What this filing means
BLUE OWL CAPITAL HOLDINGS LP filed this quarterly 13F‑HR report disclosing 76 equity positions with a total reported market value of $372.17M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
76
Positions
$372.17M
Total AUM (reported)
67.35M
Total Shares
Allocation by class
COM$303.82M81.6%
COM SHS$29.57M7.9%
COM NEW$18.76M5.0%
SPONSORED ADS$5.00M1.3%
CALL$3.24M0.9%
SHS$2.59M0.7%
CL C$2.28M0.6%
Portfolio Concentration
Top 3$118.67M31.9%
4–10$139.37M37.4%
11–25$84.49M22.7%
Rest$29.64M8.0%
Top 3 weight
31.9%
Top 10 weight
69.3%
Voting Authority Distribution
Total shares with voting rights: 0.00
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other76
Dominant voting typeNone · 0.0% of voting shares
Institutional Holdings76
Rows:
AKTIS ONCOLOGY INC
DFNDShares3.16M
TypeSH
Market value$56.56M
15.20%
Sole
0.00
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
DFNDShares7.12M
TypeSH
Market value$32.04M
8.61%
Sole
0.00
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
DFNDShares4.42M
TypeSH
Market value$30.08M
8.08%
Sole
0.00
Shared
0.00
None
0.00
NUVEEN CHURCHILL DIRECT LEND
DFNDShares2.14M
TypeSH
Market value$27.27M
7.33%
Sole
0.00
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
DFNDShares1.91M
TypeSH
Market value$27.14M
7.29%
Sole
0.00
Shared
0.00
None
0.00
BLUE OWL CAPITAL CORPORATION
DFNDShares2.05M
TypeSH
Market value$22.62M
6.08%
Sole
0.00
Shared
0.00
None
0.00
MAPLIGHT THERAPEUTICS INC
DFNDShares1.01M
TypeSH
Market value$20.45M
5.49%
Sole
0.00
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
DFNDShares2.94M
TypeSH
Market value$15.56M
4.18%
Sole
0.00
Shared
0.00
None
0.00
CONTEXT THERAPEUTICS INC
DFNDShares5.09M
TypeSH
Market value$13.33M
3.58%
Sole
0.00
Shared
0.00
None
0.00
HOLLEY INC
DFNDShares4.24M
TypeSH
Market value$13.01M
3.49%
Sole
0.00
Shared
0.00
None
0.00
EYEPOINT INC
DFNDShares912.59K
TypeSH
Market value$11.76M
3.16%
Sole
0.00
Shared
0.00
None
0.00
CORVUS PHARMACEUTICALS INC
DFNDShares545K
TypeSH
Market value$7.97M
2.14%
Sole
0.00
Shared
0.00
None
0.00
CONDUENT INC
DFNDShares5.04M
TypeSH
Market value$6.45M
1.73%
Sole
0.00
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
DFNDShares302.64K
TypeSH
Market value$6.34M
1.70%
Sole
0.00
Shared
0.00
None
0.00
AQUESTIVE THERAPEUTICS INC
DFNDShares1.35M
TypeSH
Market value$5.59M
1.50%
Sole
0.00
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
DFNDShares61.45K
TypeSH
Market value$5.34M
1.44%
Sole
0.00
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
DFNDShares904.50K
TypeSH
Market value$5.00M
1.34%
Sole
0.00
Shared
0.00
None
0.00
IMMIX BIOPHARMA INC
DFNDShares547.55K
TypeSH
Market value$4.99M
1.34%
Sole
0.00
Shared
0.00
None
0.00
IMAGENEBIO INC
DFNDShares959.34K
TypeSH
Market value$4.80M
1.29%
Sole
0.00
Shared
0.00
None
0.00
CIVEO CORP CDA
DFNDShares180.47K
TypeSH
Market value$4.78M
1.28%
Sole
0.00
Shared
0.00
None
0.00
LENZ THERAPEUTICS INC
DFNDShares506.72K
TypeSH
Market value$4.64M
1.25%
Sole
0.00
Shared
0.00
None
0.00
ELEDON PHARMACEUTICALS INC
DFNDShares1.42M
TypeSH
Market value$4.37M
1.18%
Sole
0.00
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
DFNDShares215K
TypeSH
Market value$4.33M
1.16%
Sole
0.00
Shared
0.00
None
0.00
OVID THERAPEUTICS INC
DFNDShares1.90M
TypeSH
Market value$4.23M
1.14%
Sole
0.00
Shared
0.00
None
0.00
PALVELLA THERAPEUTICS INC NE
DFNDShares31.26K
TypeSH
Market value$3.90M
1.05%
Sole
0.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AKTIS ONCOLOGY INCDFND | COM | 3.16M | SH | $56.56M 15.20% | 0.00 | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCDFND | COM | 7.12M | SH | $32.04M 8.61% | 0.00 | 0.00 | 0.00 |
ENGENE HOLDINGS INCDFND | COM | 4.42M | SH | $30.08M 8.08% | 0.00 | 0.00 | 0.00 |
NUVEEN CHURCHILL DIRECT LENDDFND | COM SHS | 2.14M | SH | $27.27M 7.33% | 0.00 | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCDFND | COM | 1.91M | SH | $27.14M 7.29% | 0.00 | 0.00 | 0.00 |
BLUE OWL CAPITAL CORPORATIONDFND | COM | 2.05M | SH | $22.62M 6.08% | 0.00 | 0.00 | 0.00 |
MAPLIGHT THERAPEUTICS INCDFND | COM | 1.01M | SH | $20.45M 5.49% | 0.00 | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCDFND | COM | 2.94M | SH | $15.56M 4.18% | 0.00 | 0.00 | 0.00 |
CONTEXT THERAPEUTICS INCDFND | COM | 5.09M | SH | $13.33M 3.58% | 0.00 | 0.00 | 0.00 |
HOLLEY INCDFND | COM | 4.24M | SH | $13.01M 3.49% | 0.00 | 0.00 | 0.00 |
EYEPOINT INCDFND | COM NEW | 912.59K | SH | $11.76M 3.16% | 0.00 | 0.00 | 0.00 |
CORVUS PHARMACEUTICALS INCDFND | COM | 545K | SH | $7.97M 2.14% | 0.00 | 0.00 | 0.00 |
CONDUENT INCDFND | COM | 5.04M | SH | $6.45M 1.73% | 0.00 | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INDFND | COM | 302.64K | SH | $6.34M 1.70% | 0.00 | 0.00 | 0.00 |
AQUESTIVE THERAPEUTICS INCDFND | COM | 1.35M | SH | $5.59M 1.50% | 0.00 | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCDFND | COM | 61.45K | SH | $5.34M 1.44% | 0.00 | 0.00 | 0.00 |
COMPASS PATHWAYS PLCDFND | SPONSORED ADS | 904.50K | SH | $5.00M 1.34% | 0.00 | 0.00 | 0.00 |
IMMIX BIOPHARMA INCDFND | COM | 547.55K | SH | $4.99M 1.34% | 0.00 | 0.00 | 0.00 |
IMAGENEBIO INCDFND | COM | 959.34K | SH | $4.80M 1.29% | 0.00 | 0.00 | 0.00 |
CIVEO CORP CDADFND | COM NEW | 180.47K | SH | $4.78M 1.28% | 0.00 | 0.00 | 0.00 |
LENZ THERAPEUTICS INCDFND | COM | 506.72K | SH | $4.64M 1.25% | 0.00 | 0.00 | 0.00 |
ELEDON PHARMACEUTICALS INCDFND | COM | 1.42M | SH | $4.37M 1.18% | 0.00 | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCDFND | COM | 215K | SH | $4.33M 1.16% | 0.00 | 0.00 | 0.00 |
OVID THERAPEUTICS INCDFND | COM | 1.90M | SH | $4.23M 1.14% | 0.00 | 0.00 | 0.00 |
PALVELLA THERAPEUTICS INC NEDFND | COM | 31.26K | SH | $3.90M 1.05% | 0.00 | 0.00 | 0.00 |
Page 1 of 4